Journal of Neuroimmune Pharmacology

, Volume 8, Issue 4, pp 888–899

Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis

INVITED REVIEW

DOI: 10.1007/s11481-013-9489-x

Cite this article as:
Zhao, W., Beers, D.R. & Appel, S.H. J Neuroimmune Pharmacol (2013) 8: 888. doi:10.1007/s11481-013-9489-x

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with selective loss of upper and lower motor neurons. At sites of motor neuron injury, neuroinflammation is a prominent pathological finding and is characterized by microglial activation, astrogliosis, and infiltration of monocytes and T-cells. Both innate and adaptive immune responses actively influence disease progression in animal models and in ALS patients, and promote neuroprotection or neurotoxicity at different stages of disease. The early immune reaction to signals from injured motor neurons is to rescue and repair damaged tissue. As disease accelerates, a shift occurs from beneficial immune responses (involving M2 microglia and regulatory T-cells) to deleterious immune responses (involving M1 microglia and Th1 cells). In this review, we underscore the importance of immune-mediated mechanisms in the pathogenesis of ALS and discuss the alterations and distinct phenotypes of immune cells at the different stages of disease. The better we understand the dynamic changes that occur within the immune system over the course of disease, the better we will be able to develop effective therapeutic regimens in ALS.

Keywords

NeuroinflammationALSNeuroprotectionNeurotoxicity

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Weihua Zhao
    • 1
  • David R. Beers
    • 1
  • Stanley H. Appel
    • 1
    • 2
  1. 1.Department of NeurologyMethodist Neurological Institute, Methodist Research Institute, The Methodist HospitalHoustonUSA
  2. 2.Department of NeurologyMethodist Neurological InstituteHoustonUSA